Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

United Nations Ban of Mercury in Vaccines Urged by U.S. Group


News provided by

Coalition for Mercury-Free Drugs (CoMeD)

08 Apr, 2011, 08:17 GMT

Share this article

Share toX

Share this article

Share toX

SILVER SPRING, Maryland, April 8, 2011 /PRNewswire/ -- CoMeD - While the United Nations (UN) actively questions the use of vaccines containing a neurotoxic mercury compound, the Coalition for Mercury-Free Drugs (CoMeD) (http://mercury-freedrugs.org), a Maryland-based, non-profit organization, is urging the UN to ban it.

In mid-March, governments were asked to send the UN secretariat "information on mercury use in pharmaceuticals, especially vaccines." The request (http://www.unep.org/hazardoussubstances/Portals/9/Mercury/Documents/INC3/Overview%20of%20documents%20for%20INC3_15%20March%202011_.pdf) was made in preparation for the United Nations Environmental Programme's third intergovernmental negotiating committee (INC3) (http://www.unep.org/hazardoussubstances/Mercury/Negotiations/INC3/tabid/3469/Default.aspx) on mercury, which is scheduled for this fall. The purpose of the INC meetings is to develop a legally-binding, global mercury treaty by 2013.

CoMeD (http://mercury-freedrugs.org) was pleased by this call for information because CoMeD provided scientific data about health hazards caused by mercury in vaccines to various international delegates at the second INC meeting (http://www.unep.org/hazardoussubstances/Mercury/Negotiations/INC2/tabid/3468/Default.aspx) in January in Chiba, Japan.

Since then, CoMeD (http://mercury-freedrugs.org) has publicized new studies proving that mercury in vaccines (http://www.ncbi.nlm.nih.gov/pubmed/21225508) and dental amalgams, or "silver" fillings (http://www.occup-med.com/content/6/1/2), is associated with neurological diseases (http://jpp.krakow.pl/journal/archive/12_10/articles/14_article.html) such as autism (http://informahealthcare.com/doi/abs/10.3109/1547691X.2010.545086) in children and Alzheimer's disease (http://iospress.metapress.com/content/j33p87808363493j/fulltext.pdf) in adults.

One recent study, from Mansoura University in Egypt (http://journals.lww.com/mecpsychiatry/Fulltext/2011/01000/Study_of_some_biomarkers_in_hair_of_children_with.2.aspx?WT.mc_id=HPxADx20100319xMP), explores the connection between heavy metals and learning/behavioral disorders in children. The authors cite Thimerosal (http://www.vaccine-tlc.org/docs/Thimerosal%20Material%20Safety%20Data%20Sheet.pdf), a mercury-based compound used as a preservative in certain vaccines, as a possible factor in autism. They specifically note that research shows "exposure to heavy metals, such as lead and mercury, can impair brain development at very early ages, even at low doses that were earlier deemed 'harmless.'"

Additionally, articles recently published in Folia Neuropathologica (http://www.ncbi.nlm.nih.gov/pubmed/21225508), Neurochemical Research (http://www.springerlink.com/content/22115401745m3l44/), the Journal of Immunotoxicology (http://informahealthcare.com/doi/abs/10.3109/1547691X.2010.545086), the Journal of Occupational Medicine and Toxicology (http://www.occup-med.com/content/6/1/2), and the Journal of Physiology and Pharmacology (http://jpp.krakow.pl/journal/archive/12_10/articles/14_article.html) confirm the toxicity of the dose of mercury in Thimerosal-preserved vaccines (http://mercury-freedrugs.org/docs/090813_fnldrft_EditorialOnSubacuteMercury(Hg)PoisoningByMedicine_r6b.pdf).

In 1999, the U.S. Public Health Service and American Academy of Pediatrics called for Thimerosal to be removed from the U.S. Thimerosal-preserved vaccines (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4826a3.htm) "as soon as possible," and Thimerosal has since been removed from most of these U.S. vaccines. A CoMeD analysis (http://mercury-freedrugs.org/docs/20110105_CoMeD_onepager_Preservatives_rb.pdf) shows that replacing Thimerosal (http://www.hhs.gov/fda/faq/vaccines/1858.html) with 2-phenoxyphenol in worldwide vaccines is both safe and economical. Additionally, CoMeD has sued the FDA (http://www.prnewswire.com/news-releases/comed-sues-fda-to-force-mercury-out-of-medicine-55926807.html) for its failure to comply with the law and enforce preservative safety regulations.

Furthermore, proponents of vaccine safety are asking organizations and individuals who are responsible for international vaccination campaigns, such as those in Africa, to heed the overwhelming scientific research about the human health risks linked to mercury (Thimerosal) and other vaccine ingredients (http://www.cbsnews.com/8301-31727_162-20049118-10391695.html).

Rev. Lisa K. Sykes (http://www.umc.org/site/apps/nlnet/content2.aspx?c=lwL4KnN1LtH&b=6297653&ct=6903307), President of CoMeD (http://mercury-freedrugs.org), is warning groups including the Global Alliance for Vaccines, the United Nations Children's Fund (UNICEF), and the Bill and Melinda Gates Foundation to stop spreading mercury to other continents: "While Thimerosal has been removed from most vaccines in the United States, pharmaceutical companies and the World Health Organization continue to dump mercury-laced vaccines on developing countries. No ethic can justify providing prosperous nations with mercury-free vaccines while endangering children in poor nations by exposing them to this neurotoxin."

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.